141 related articles for article (PubMed ID: 19997775)
1. Effect of autogenic training on general improvement in patients with irritable bowel syndrome: a randomized controlled trial.
Shinozaki M; Kanazawa M; Kano M; Endo Y; Nakaya N; Hongo M; Fukudo S
Appl Psychophysiol Biofeedback; 2010 Sep; 35(3):189-98. PubMed ID: 19997775
[TBL] [Abstract][Full Text] [Related]
2. Subjective theories of illness and clinical and psychological outcomes in patients with irritable bowel syndrome.
Riedl A; Maass J; Fliege H; Stengel A; Schmidtmann M; Klapp BF; Mönnikes H
J Psychosom Res; 2009 Nov; 67(5):449-55. PubMed ID: 19837208
[TBL] [Abstract][Full Text] [Related]
3. A randomized controlled trial of cognitive behavior therapy, relaxation training, and routine clinical care for the irritable bowel syndrome.
Boyce PM; Talley NJ; Balaam B; Koloski NA; Truman G
Am J Gastroenterol; 2003 Oct; 98(10):2209-18. PubMed ID: 14572570
[TBL] [Abstract][Full Text] [Related]
4. Structured patient education is superior to written information in the management of patients with irritable bowel syndrome: a randomized controlled study.
Ringström G; Störsrud S; Posserud I; Lundqvist S; Westman B; Simrén M
Eur J Gastroenterol Hepatol; 2010 Apr; 22(4):420-8. PubMed ID: 19923998
[TBL] [Abstract][Full Text] [Related]
5. Determinants of quality of life in irritable bowel syndrome.
Rey E; García-Alonso MO; Moreno-Ortega M; Alvarez-Sanchez A; Diaz-Rubio M
J Clin Gastroenterol; 2008 Oct; 42(9):1003-9. PubMed ID: 18719505
[TBL] [Abstract][Full Text] [Related]
6. Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.
Jerndal P; Ringström G; Agerforz P; Karpefors M; Akkermans LM; Bayati A; Simrén M
Neurogastroenterol Motil; 2010 Jun; 22(6):646-e179. PubMed ID: 20367800
[TBL] [Abstract][Full Text] [Related]
7. Differences in the health-related quality of life, affective status, and personality between irritable bowel syndrome and inflammatory bowel disease patients.
Tkalcić M; Hauser G; Stimac D
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):862-7. PubMed ID: 19701092
[TBL] [Abstract][Full Text] [Related]
8. A randomized, double-blind, placebo-controlled multicenter trial of saccharomyces boulardii in irritable bowel syndrome: effect on quality of life.
Choi CH; Jo SY; Park HJ; Chang SK; Byeon JS; Myung SJ
J Clin Gastroenterol; 2011 Sep; 45(8):679-83. PubMed ID: 21301358
[TBL] [Abstract][Full Text] [Related]
9. A randomized controlled trial of a cognitive behavioural therapy-based self-management intervention for irritable bowel syndrome in primary care.
Moss-Morris R; McAlpine L; Didsbury LP; Spence MJ
Psychol Med; 2010 Jan; 40(1):85-94. PubMed ID: 19531276
[TBL] [Abstract][Full Text] [Related]
10. Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome.
van der Veek PP; van Rood YR; Masclee AA
Aliment Pharmacol Ther; 2007 Sep; 26(6):943-52. PubMed ID: 17767479
[TBL] [Abstract][Full Text] [Related]
11. Subjective health complaints and quality of life in patients with irritable bowel syndrome following Giardia lamblia infection: a case control study.
Morken MH; Lind RA; Valeur J; Wilhelmsen I; Berstad A
Scand J Gastroenterol; 2009; 44(3):308-13. PubMed ID: 19031266
[TBL] [Abstract][Full Text] [Related]
12. A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome.
Drouault-Holowacz S; Bieuvelet S; Burckel A; Cazaubiel M; Dray X; Marteau P
Gastroenterol Clin Biol; 2008 Feb; 32(2):147-52. PubMed ID: 18387426
[TBL] [Abstract][Full Text] [Related]
13. Impact of functional bowel symptoms on quality of life and fatigue in quiescent Crohn disease and irritable bowel syndrome.
Piche T; Ducrotté P; Sabate JM; Coffin B; Zerbib F; Dapoigny M; Hua M; Marine-Barjoan E; Dainese R; Hébuterne X
Neurogastroenterol Motil; 2010 Jun; 22(6):626-e174. PubMed ID: 20403099
[TBL] [Abstract][Full Text] [Related]
14. Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial.
Johannesson E; Simrén M; Strid H; Bajor A; Sadik R
Am J Gastroenterol; 2011 May; 106(5):915-22. PubMed ID: 21206488
[TBL] [Abstract][Full Text] [Related]
15. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
Ducrotte P; Dapoigny M; Bonaz B; Siproudhis L
Aliment Pharmacol Ther; 2005 Feb; 21(4):435-44. PubMed ID: 15709995
[TBL] [Abstract][Full Text] [Related]
16. A population-based case-control study of work and psychosocial problems in patients with irritable bowel syndrome--women are more seriously affected than men.
Faresjö A; Grodzinsky E; Johansson S; Wallander MA; Timpka T; Akerlind I
Am J Gastroenterol; 2007 Feb; 102(2):371-9. PubMed ID: 17156145
[TBL] [Abstract][Full Text] [Related]
17. Long-term success of GUT-directed group hypnosis for patients with refractory irritable bowel syndrome: a randomized controlled trial.
Moser G; Trägner S; Gajowniczek EE; Mikulits A; Michalski M; Kazemi-Shirazi L; Kulnigg-Dabsch S; Führer M; Ponocny-Seliger E; Dejaco C; Miehsler W
Am J Gastroenterol; 2013 Apr; 108(4):602-9. PubMed ID: 23419384
[TBL] [Abstract][Full Text] [Related]
18. Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome--a randomized controlled trial.
Ljótsson B; Falk L; Vesterlund AW; Hedman E; Lindfors P; Rück C; Hursti T; Andréewitch S; Jansson L; Lindefors N; Andersson G
Behav Res Ther; 2010 Jun; 48(6):531-9. PubMed ID: 20362976
[TBL] [Abstract][Full Text] [Related]
19. Hypnosis home treatment for irritable bowel syndrome: a pilot study.
Palsson OS; Turner MJ; Whitehead WE
Int J Clin Exp Hypn; 2006 Jan; 54(1):85-99. PubMed ID: 16316885
[TBL] [Abstract][Full Text] [Related]
20. Irritable bowel syndrome in haemodialysis: Prevalence, link with quality of life and depression.
Afsar B; Elsurer R; Yilmaz MI; Eyileten T; Yenicesu M
Nephrology (Carlton); 2010 Mar; 15(2):197-202. PubMed ID: 20470279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
